Safety Data SheetChemical Risk Assessment

Galliprant Tablets

by Elanco New Zealand

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Galliprant Tablets is supplied by Elanco New Zealand under product code CA5810; CA5811; CA5812; 20 mg Galliprant Tablet; 100 mg Galliprant Tablet; 60 mg Galliprant Tablet; Galliprant Tablets. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 11 March 2020. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
GHS/CLP
Revision Date
11 Mar 2020
Signal Word
WARNING
Product Code
CA5810; CA5811; CA5812; 20 mg Galliprant Tablet; 100 mg Galliprant Tablet; 60 mg Galliprant Tablet; Galliprant Tablets
CAS Number

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: WARNING

EnvironmentGHS09Environment
Hazard Statements (H-phrases)
H400
Very toxic to aquatic life.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US